
Lu-177:
  h(10) [uSv/h per MBq/m^2]:  0.0063
  labda [s^-1]: 1.2e-6
  Energy [keV]:
    - 55.79
    - 63 # two peaks combined
    - 112.948
    - 208.37
  Abundance:
    - 2.77E-2
    - 0.91E-2
    - 6.17e-2
    - 10.36e-2


I-131:
  h(10) [uSv/h per MBq/m^2]:  0.066
  labda [s^-1]: 1.0e-6
  Energy [keV]:
    - 80.185
    - 284.305
    - 364.489
    - 636.989
 #   - 722.911
  Abundance:
    - 2.62e-2
    - 6.12e-2
    - 81.5e-2
    - 7.16e-2
 #   - 1.77e-2
I-131 Body:
  h(10) [uSv/h per MBq/m^2]:  0.034
  labda [s^-1]: 2.41e-5         # 8 hours halflife
  Energy [keV]:
    - 80.185
    - 284.305
    - 364.489
    - 636.989
#    - 722.911
  Abundance: # reduction by factor 2 of 365 keV
    - 2.62e-2
    - 6.12e-2
    - 41.0e-2
    - 7.16e-2
 #   - 1.77e-2
F-18:
  h(10) [uSv/h per MBq/m^2]: 0.166
  labda [s^-1]: 1.05e-4
  Energy [keV]:
    - 511
  Abundance:
    - 2
Ga-68:
  h(10) [uSv/h per MBq/m^2]: 0.16
  labda [s^-1]: 2.79e-8
  Energy [keV]:
    - 511
    - 1077
  Abundance:
    - 1.780
    - 0.033
Ho-166:
  h(10) [uSv/h per MBq/m^2]: 0.005 # estimated 40 uSv/h for a 60 Gy therapy dose (Figure 1.), median injected activity 4510 MBq (Table 2)
  labda [s^-1]: 7.18E-6
  Energy [keV]:
    - 48.6 # two close peaks summed
    - 56 # two close peaks summed
    - 80.576
    - 1379.437
    - 1581.834
  Abundance:
    - 2.96E-2
    - 6.84E-2
    - 6.56E-2
    - 0.922E-2
    - 0.182E-2